Suchergebnisse - "Nederby, Line"

PubPharm (52)

1

Soluble programmed death ligand 1 as prognostic biomarker in non-small cell lung cancer patients receiving nivolumab, pembrolizumab or atezolizumab therapy

enthalten in: Scientific reports | 2024

von Brun, S. | Hansen, T. | Wen, S. | +5

2

Description of an activity-based enzyme biosensor for lung cancer detection

enthalten in: Communications medicine | 2024

von Dempsey, P. | Sandu, C. | Gonzalezirias, R. | +14

3

NK cell activity and methylated HOXA9 ctDNA as prognostic biomarkers in patients with non-small cell lung cancer treated with PD-1/PD-L1 inhibitors

enthalten in: British journal of cancer | 2023

von Wen, S. | Nederby, L. | Andersen, R. | +5

4

Assessment of circulating biomarkers for detection of lung cancer in a high-risk cohort

enthalten in: Cancer biomarkers : section A of Disease markers | 2023

von Borg, M. | Nederby, L. | Wen, S. | +5

5

High Expression of the Costimulatory Checkpoint Factor DNAM-1 by CD4+ T-Cells from Multiple Myeloma Patients Refractory to Daratumumab-Containing Regimens

enthalten in: Clinical hematology international | 2022

von Iversen, K. | Nederby, L. | Lund, T. | +1

6

High Expression of the Costimulatory Checkpoint Factor DNAM-1 by $ CD4^{+} $ T-Cells from Multiple Myeloma Patients Refractory to Daratumumab-Containing Regimens

enthalten in: Clinical hematology international | 2022

von Iversen, K. | Nederby, L. | Lund, T. | +1

7

High Expression of the Costimulatory Checkpoint Factor DNAM-1 by $ CD4^{+} $ T-Cells from Multiple Myeloma Patients Refractory to Daratumumab-Containing Regimens

enthalten in: Clinical hematology international | 2022

von Iversen, K. | Nederby, L. | Lund, T. | +1

8

Natural killer cell activity as a biomarker for the diagnosis of lung cancer in high-risk patients

enthalten in: The Journal of international medical research | 2022

von Borg, M. | Wen, S. | Hansen, T. | +5

9

Acute myeloid leukemia exhibiting clonal instability during treatment : Implications for measurable residual disease assessments

enthalten in: Experimental hematology | 2022

von Simonsen, A. | Meggendorfer, M. | Hansen, M. | +9

10

Validating Methylated HOXA9 in Bronchial Lavage as a Diagnostic Tool in Patients Suspected of Lung Cancer

enthalten in: Cancers | 2021

von Wen, S. | Andersen, R. | Rasmussen, K. | +6

1
2
3
4
5
6
Nächster »
[6]